Plasma concentrations of 5-FU and creatinine clearance as predictive markers for severe toxicities of capecitabine in patients with colorectal cancer.
Katsuya Makihara
No relevant relationships to disclose
Hideyuki Mishima
No relevant relationships to disclose
Sayaka Azuma
No relevant relationships to disclose
Kazuyo Miyagi
No relevant relationships to disclose
Katsuya Komori
No relevant relationships to disclose
Hiroko Hasegawa
No relevant relationships to disclose
Masayoshi Yasui
No relevant relationships to disclose
Masakazu Ikenaga
No relevant relationships to disclose
Toshimasa Tsujinaka
No relevant relationships to disclose